Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$110.4m
reported value
-27.6% vs Q2 2023
12positions
98.1%in top 10
0 new
3 added
7 reduced
0 sold out
vs Q2 2023
Holdings, Q3 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $24.4m22.12% | Added +50.0k |
| BLUEPRINT MEDICINES CORP BPMC | $19.0m17.25% | Reduced -69.9k |
| REGENXBIO INC RGNX | $13.9m12.64% | Reduced -22.7k |
| SILENCE THERAPEUTICS PLC SLN | $12.9m11.68% | Unchanged |
| KYMERA THERAPEUTICS INC KYMR | $10.9m9.85% | Added +130.9k |
| MERUS N V MRUS | $10.1m9.19% | Reduced -345.0k |
| ARVINAS INC ARVN | $9.6m8.71% | Reduced -134.8k |
| C4 THERAPEUTICS INC CCCC | $3.7m3.35% | Added +1.2m |
| GENMAB A/S GMAB | $1.8m1.67% | Reduced -122.5k |
| ARGENX SE ARGX | $1.8m1.66% | Reduced -12.6k |
| OLEMA PHARMACEUTICALS INC OLMA | $1.1m0.99% | Reduced -161.1k |
| PIERIS PHARMACEUTICALS INC COM | $984.4k0.89% | Unchanged |